MicroTransponder is a medical technology company focused on improving the quality of life for patients with chronic neurological conditions through its Paired Vagus Nerve Stimulation (VNS) platform. The company's FDA-approved Vivistim System is designed to help stroke patients, specifically those with chronic ischemic stroke, regain motor function in the arms and hands. By combining Vagus Nerve Stimulation with rehabilitation therapy, their system aims to provide 2-3 times more improvement in motor function compared to rehabilitation alone. MicroTransponder is committed to advancing neurological recovery by applying key principles such as increased neuromodulators, high repetition therapy, and self-activation portability in their therapies.